跳至主要内容
临床试验/ACTRN12614000089639
ACTRN12614000089639已完成未知

Safety and efficacy of 23-gauge vitrectomy and silicone oil tamponade combined with and without phacoemulsification in patients undergoing vitreoretinal surgery.

SB Ankara Ulucanlar Eye Education and Research Hospital, Ankara, Turkey0 个研究点目标入组 38 人开始时间: 2014年1月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
38

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
38 Years 至 60 Years(—)
性别
All

入选标准

  • The patients that underwent 23-gauge vitrectomy and silicone oil tamponade combined with and without phacoemulsification with following conditions included the study; rhegmatogenous retinal detachment, proliferative diabetic retinopathy with tractional retinal detachment, proliferative diabetic retinopathy with nonclearing vitreous hemorrhage, central retinal vein occlusion with vitreous hemorrhage and idiopathic epiretinal membrane.

排除标准

  • Patients with a history of prior vitreoretinal surgery and any corneal pathology were excluded from the study

研究者

发起方
SB Ankara Ulucanlar Eye Education and Research Hospital, Ankara, Turkey

相似试验